TY - JOUR
T1 - Covid-19 vaccines safety tracking (Covast)
T2 - Protocol of a multi-center prospective cohort study for active surveillance of covid-19 vaccines’ side effects
AU - Riad, Abanoub
AU - Schünemann, Holger
AU - Attia, Sameh
AU - Peričić, Tina Poklepović
AU - Žuljević, Marija Franka
AU - Jürisson, Mikk
AU - Kalda, Ruth
AU - Lang, Katrin
AU - Morankar, Sudhakar
AU - Yesuf, Elias Ali
AU - Mekhemar, Mohamed
AU - Danso-Appiah, Anthony
AU - Sofi-Mahmudi, Ahmad
AU - Pérez-Gaxiola, Giordano
AU - Dziedzic, Arkadiusz
AU - Apóstolo, João
AU - Cardoso, Daniela
AU - Marc, Janja
AU - Moreno-Casbas, Mayte
AU - Wiysonge, Charles Shey
AU - Qaseem, Amir
AU - Gryschek, Anna
AU - Tadić, Ivana
AU - Hussain, Salman
AU - Khan, Mohammed Ahmed
AU - Klugarova, Jitka
AU - Pokorna, Andrea
AU - Koščík, Michal
AU - Klugar, Miloslav
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/8/1
Y1 - 2021/8/1
N2 - Background: Coronavirus disease (COVID-19) vaccine-related side effects have a deter-minant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses’ side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the iden-tifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.
AB - Background: Coronavirus disease (COVID-19) vaccine-related side effects have a deter-minant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses’ side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the iden-tifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.
KW - COVID-19
KW - Cohort studies
KW - Cross-sectional studies
KW - Drug-related side effects and adverse reactions
KW - Health personnel
KW - Mass vaccination
KW - Prevalence
UR - https://www.scopus.com/pages/publications/85111058565
U2 - 10.3390/ijerph18157859
DO - 10.3390/ijerph18157859
M3 - Article
C2 - 34360156
AN - SCOPUS:85111058565
SN - 1661-7827
VL - 18
JO - International Journal of Environmental Research and Public Health
JF - International Journal of Environmental Research and Public Health
IS - 15
M1 - 7859
ER -
